Skip to main content

CombiMatrix Molecular Dx, Alpha Innotech to Integrate Tools for CGH Research

NEW YORK (GenomeWeb News) - Alpha Innotech and CombiMatrix Molecular Diagnostics will integrate certain of their technologies to create a tool for comparative genomic hybridization, the companies said yesterday.
 
The deal is centered on Alpha's AlphaScan laser scanner and CMDX's CGH arrays for neonatal screening and biomarker discovery, and calls for CMDX to integrate the AlphaScan scanner into its CGH platform.
 
CMDX CEO Matt Watson said his firm's customers "are looking for a single integrated platform that will enable them to quickly set up a CGH laboratory and begin running experiments." He said the AlphaScan "represents a key component of that platform."
 
Financial terms were not disclosed.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.